ATE411812T1 - Peptide zur behandlung von infektionen mit dem herpes-virus - Google Patents

Peptide zur behandlung von infektionen mit dem herpes-virus

Info

Publication number
ATE411812T1
ATE411812T1 AT05786951T AT05786951T ATE411812T1 AT E411812 T1 ATE411812 T1 AT E411812T1 AT 05786951 T AT05786951 T AT 05786951T AT 05786951 T AT05786951 T AT 05786951T AT E411812 T1 ATE411812 T1 AT E411812T1
Authority
AT
Austria
Prior art keywords
peptides
herpes virus
virus infections
treating herpes
peptide
Prior art date
Application number
AT05786951T
Other languages
English (en)
Inventor
Wolf-Georg Forssmann
Frank Kirchhoff
Jan Muench
Ludger Staendker
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Application granted granted Critical
Publication of ATE411812T1 publication Critical patent/ATE411812T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05786951T 2004-08-18 2005-08-16 Peptide zur behandlung von infektionen mit dem herpes-virus ATE411812T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60231304P 2004-08-18 2004-08-18
EP04019552 2004-08-18

Publications (1)

Publication Number Publication Date
ATE411812T1 true ATE411812T1 (de) 2008-11-15

Family

ID=34926208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05786951T ATE411812T1 (de) 2004-08-18 2005-08-16 Peptide zur behandlung von infektionen mit dem herpes-virus

Country Status (7)

Country Link
US (1) US7741287B2 (de)
EP (1) EP1778271B1 (de)
JP (1) JP5101280B2 (de)
AT (1) ATE411812T1 (de)
CA (1) CA2558289C (de)
DK (1) DK1778271T3 (de)
WO (1) WO2006018431A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005010590D1 (de) * 2004-08-18 2008-12-04 Ipf Pharmaceuticals Gmbh Peptide zur behandlung von infektionen mit dem herpes-virus
IT1395137B1 (it) 2009-08-05 2012-09-05 Spider Biotech S R L Nuovi peptidi antipatogeni
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético
EP2789343A1 (de) * 2013-04-11 2014-10-15 Clinique La Prairie Neue hämoglobinabgeleitete peptidbasierte pharmazeutische Zusammensetzungen
JP6464507B2 (ja) * 2014-12-24 2019-02-06 国立大学法人秋田大学 抗ウイルス剤、および抗菌剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS649997A (en) 1987-07-02 1989-01-13 Toray Industries Serine protease inhibitor
US5922854A (en) * 1991-06-14 1999-07-13 Kumar; Ramesh Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
DE69431473T2 (de) * 1993-03-31 2003-08-07 Pro-Neuron, Inc. Inhibitor der stammzellproliferation und seine verwendung
US6610654B2 (en) * 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
JP2000516455A (ja) * 1996-08-02 2000-12-12 バクスター バイオテック テクノロジー エス．アー．エール．エル． ヘモグロビンにおけるβダイマー形成を制御する方法
WO1999017786A1 (en) * 1997-10-08 1999-04-15 Theragem, Inc. Mammalian-derived peptides for the treatment of microbial infection
EP1481988A3 (de) 2000-06-08 2005-02-23 IPF PharmaCeuticals GmbH Verfahren zur Gewinnung und Anwendung von antibiotisch wirksamen Peptiden zur Behandlung von Infektionskrankheiten
GB0125793D0 (en) 2001-10-26 2001-12-19 Panzeri Ezio Method

Also Published As

Publication number Publication date
CA2558289A1 (en) 2006-02-23
EP1778271B1 (de) 2008-10-22
JP5101280B2 (ja) 2012-12-19
WO2006018431A2 (en) 2006-02-23
US7741287B2 (en) 2010-06-22
US20080312144A1 (en) 2008-12-18
WO2006018431A3 (en) 2006-06-08
JP2008509969A (ja) 2008-04-03
EP1778271A2 (de) 2007-05-02
DK1778271T3 (da) 2009-02-16
CA2558289C (en) 2018-05-15

Similar Documents

Publication Publication Date Title
MXPA03000626A (es) Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
CY1108009T1 (el) Αποτελεσματικα πεπτιδια στη θεραπεια ογκων ή αλλων ασθενειων που απαιτουν την εξαιρεση ή καταστροφη κυτταρων
WO2002008251A3 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
DE602004029812D1 (de) Fgf-5-bindende und geträgerte peptide
WO2002008256A3 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
CY1106334T1 (el) Βελτιστοποιημενου κωδικονιου αλληλουχιες ιου θηλωματος
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
NO20063026L (no) Antistoffer
WO2005002526A3 (en) Method and compositions for treatment of viral infections
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
RU2010110564A (ru) Пептид cdca1 и включающее его фармацевтическое средство
WO2005007078A3 (en) Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars)
DE60024100D1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
JP2006506942A5 (de)
MX2008009493A (es) Peptido novedoso y uso del mismo.
ATE536745T1 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
TW200732351A (en) New cyclic peptide compounds
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
RU2005123050A (ru) Супер-антигенные фьюжн-белки и их использование
EA201892322A1 (ru) Способ лечения или предупреждения остеоартрита
IL158981A0 (en) Tsg101 as inhibitor of hiv production

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties